QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 专题：中南大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis 期刊论文 European Journal of Preventive Cardiology, 2017, 卷号: 24, 期号: 9, 页码: 907-916 作者:  Gui, Ya-jun;  Liao, Cai-xiu;  Liu, Qiong;  Guo, Yuan;  Yang, Tao 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/03 *Hydroxymethylglutaryl-CoA reductase inhibitors  *dyslipidemia  *exercise   Effects of aerobic exercise on lipids and lipoproteins 期刊论文 Lipids in Health and Disease, 2017, 卷号: 16, 期号: 1, 页码: 132 作者:  Wang, Yating;  Xu, Danyan* 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/03 Aerobic exercise  Coronary heart disease  Dyslipidemia  Lipoprotein   Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study 期刊论文 JOURNAL OF GLOBAL HEALTH, 2017, 卷号: 7, 期号: 2, 页码: 020702 作者:  Ding, Rongjing;  Ye, Ping;  Zhao, Shuiping;  Zhao, Dong;  Yan, Xiaowei 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials 期刊论文 Molecular Psychiatry, 2016, 卷号: 21, 期号: 11, 页码: 1537-1544 作者:  Wu, R-R*;  Zhang, F-Y;  Gao, K-M;  Ou, J-J;  Shao, P 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/03 Sphingosine 1-phosphate in metabolic syndrome (Review). 期刊论文 International Journal of Molecular Medicine, 2016, 卷号: 38, 期号: 4, 页码: 1030-1038 作者:  Chen, Wei;  Lu, Hongwei*;  Yang, Jie;  Xiang, Hong;  Peng, Hui 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 metabolic syndrome  sphingosine 1-phosphate  obesity  insulin resistance  hyperglycemia  dyslipidemia  hypertension   Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: Subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China) 期刊论文 Atherosclerosis, 2014, 卷号: 237, 期号: 1, 页码: 99-105 作者:  Wang, Fan;  Ye, Ping*;  Hu, Dayi;  Min, Ying;  Zhao, Shuiping 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03 Metabolic syndrome  Dyslipidemia  Anticholesteremic agents  LDL cholesterol  Non-HDL cholesterol  Goal attainment   Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study 期刊论文 Journal of Clinical Lipidology, 2014, 卷号: 8, 期号: 6, 页码: 568-575 作者:  Moriarty, Patrick M;  Roth, Eli M;  Karns, Adam;  Ye, Ping;  Zhao, Shui-Ping 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 Atherosclerosis  Cholesterol  Lovastatin  Red yeast rice  Xuezhikang   Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS) 期刊论文 Atherosclerosis, 2014, 卷号: 235, 期号: 2, 页码: 463-469 作者:  Zhao, Shuiping;  Wang, Yongjun;  Mu, Yiming;  Yu, Bilian;  Ye, Ping 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/03 Cardiovascular diseases  Dyslipidaemia  Statin  Lipid-lowering agents  LDL cholesterol  Non-HDL cholesterol   Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control 期刊论文 Population Health Metrics, 2014, 卷号: 12, 期号: 1, 页码: 28 作者:  Huang, Yuanxiu;  Gao, Lin;  Xie, Xiaoping;  Tan, Seng Chuen* 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03 Awareness rate  Control rate  Dyslipidemia  Meta-analysis  Prevalence  Treatment rate   The next generation of novel low-density lipoprotein cholesterol-lowering agents: Proprotein convertase subtilisin/kexin 9 inhibitors 期刊论文 Pharmacological Research, 2013, 卷号: 73, 页码: 27-34 作者:  Shen, Li;  Peng, Hongchun;  Xu, Danyan*;  Zhao, Shuiping 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 Proprotein convertase subtilisin/kexin 9  LDL receptor  LDL cholesterol  Gain-of-function mutation  PCSK9 inhibitor  Dyslipidemia